{
  "id": 21073570,
  "title": "Alcohol may weaken cancer immunotherapy, early research suggests",
  "url": "https://urgent.news/2026/11/21/alcohol-may-weaken-cancer-immunotherapy-early-research-suggests",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-21T16:00:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-alcohol-weaken-cancer-immunotherapy-early.html"
  },
  "original_language": "en",
  "account": "Alcohol may hinder the effectiveness of cancer immunotherapy, according to early research. Immune checkpoint inhibitors (ICIs), which include anti-programmed cell death protein 1 (PD-1) therapies, are drugs that help the body's immune system target tumor cells. Studies in mice and human patients revealed that moderate-to-heavy alcohol consumption reduced the efficacy of ICIs by nearly half in mice with lung and bladder cancer, and more than one drink per week was linked to reduced survival benefits in lung cancer patients. Alcohol interferes with T cells, the immune cells that seek out and destroy cancer cells, by increasing the inhibitory receptor TIGIT and reducing the activation of CD8+ T cells, which produce key tumor-fighting signals. When anti-PD-1 therapy was combined with an anti-TIGIT antibody in alcohol-exposed mice, the combination restored complete tumor response rates to nearly the same level as in mice that had not consumed alcohol. Further studies are needed to better understand the impact of alcohol on ICIs.",
  "summary": "Cancer immunotherapy has transformed treatment for several advanced cancers, yet the difference between these treatments working and not could depend on simple routine habits. A recent study published in Science Signaling explores one such overlooked factor: regular alcohol consumption.",
  "key_points": [
    "Moderate-to-heavy alcohol intake linked to reduced survival benefits in lung cancer patients.",
    "Alcohol interferes with T cells, increasing TIGIT and reducing CD8+ T cell activation."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}